The Educated Patient Parkinson Disease Resource Guide
This downloadable PDF presents a collection of resources, information and support for patients with Parkinson disease and their caregivers. The Educated Patient Parkinson Disease Resource Guide provides information about the disease, treatment options and ways for patients to cope with a Parkinson disease diagnosis and also includes a Weekly Symptoms Checklist tracker, Questions to Ask Your Physician and Frequently Asked Questions.
June 6th 2022, 10:00 am EDT
Peer Exchange: Updates in the Management of Relapsing Multiple Sclerosis
This downloadable PDF provides you with insight and best practices from a collective of experts in the management of multiple sclerosis on the diagnosis and treatment of the disease, with a focus on the latest first-line therapies, balancing quality of life, managing fatigue, and the pipeline of future agents.
December 21st 2020, 12:00 am EST
Prescriber's Guide to Lasmiditan
In October 2019, the FDA approved Eli Lilly's lasmiditan, marketed as Reyvow, for the acute treatment of migraine with or without aura in adults. The drug is the first approved from a new class of serotonin (5-HT)1F receptor agonists. This downloadable PDF serves as a convenient, consolidated prescribing guide to help you incorporate this new migraine therapy into your clinical practice.
October 12th 2020, 10:00 am EDT
11 Essential Neurology Guideline Updates
This downloadable PDF provides you with the most recent updates to key clinical guidelines for the treatment of various neurologic disorders. The guide includes new and updated guideline recommendations from US-, Canadian-, and European-based organizations on management of tic disorders, ischemic stroke, Parkinson disease, pediatric migraine, trigeminal neuralgia, and more.
October 11th 2020, 10:00 am EDT
A Physician's Guide to Critical Neurology Conditions eBook
This eBook takes an in-depth look into the NeurologyLive® clinical focus coverage across a variety of media platforms. This resource covers breaking news, interviews with top experts and coverage of FDA approvals.
October 8th 2020, 10:00 am EDT